News|Articles|February 3, 2026
Turning Abandonment Scenarios into Patient Starts
Author(s)CoverMyMeds
Discover three strategies for overcoming high costs, prior authorization delays and rejected claims.
Trending on PharmExec
1
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
2
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
3
Pharmaceutical Executive Daily: FDA Approves Simtriyo
4
Why Gross-to-Net Internal Controls Should Be a Launch Priority for Specialty Pharma Companies
5